SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Gao, X.-F. Ji, F. Li, F.-K. Sun, J. Zhao, Y.-C. Fan, K. Wang, Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 predicts prognosis of acute-on-chronic hepatitis B liver failure, Journal of Viral Hepatitis, 2014, 21, 10
  2. 2
    Laura Lladó, Javier Bustamante, IV Reunión de Consenso de la Sociedad Española de Trasplante Hepático 2012. Excepciones al Model for End-stage Liver Disease en la priorización para trasplante hepático, Gastroenterología y Hepatología, 2014, 37, 2, 83

    CrossRef

  3. 3
    Michael D. Leise, John J. Poterucha, Patrick S. Kamath, W. Ray Kim, Management of Hepatic Encephalopathy in the Hospital, Mayo Clinic Proceedings, 2014, 89, 2, 241

    CrossRef

  4. 4
    Adam Deising, Rohit Satoskar, MELD: Which Patients Fall Through the Cracks?, Current Hepatology Reports, 2014, 13, 1, 60

    CrossRef

  5. 5
    Youn Yi Jo, Yong Seon Choi, Dong Jin Joo, Young-Chul Yoo, Seung Gyun Nam, Shin Ok Koh, Pretransplant mortality predictors in living and deceased donor liver transplantation, Journal of the Chinese Medical Association, 2014, 77, 1, 16

    CrossRef

  6. 6
    Sara Montagnese, Michele Rui, Sami Schiff, Elena Ceranto, Pietro Valenti, Paolo Angeli, Umberto Cillo, Giacomo Zanus, Angelo Gatta, Piero Amodio, Carlo Merkel, Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG, Liver International, 2014, 34, 9
  7. 7
    Kevin D. Mullen, Arun J. Sanyal, Nathan M. Bass, Fred F. Poordad, Muhammad Y. Sheikh, R. Todd Frederick, Enoch Bortey, William P. Forbes, Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy, Clinical Gastroenterology and Hepatology, 2014, 12, 8, 1390

    CrossRef

  8. 8
    M.-H. Zheng, K.-Q. Shi, X.-F. Lin, D.-D. Xiao, L.-L. Chen, W.-Y. Liu, Y.-C. Fan, Y.-P. Chen, A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network, Journal of Viral Hepatitis, 2013, 20, 4
  9. 9
    Yun-Hsuan Lee, Chia-Yang Hsu, Teh-Ia Huo, Assessing liver dysfunction in cirrhosis: Role of the model for end-stage liver disease and its derived systems, Journal of the Chinese Medical Association, 2013, 76, 8, 419

    CrossRef

  10. 10
    A. Goldbecker, K. Weissenborn, G. Hamidi Shahrezaei, K. Afshar, S. Rumke, H. Barg-Hock, C. P. Strassburg, H. Hecker, A. B. Tryc, Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates, Gut, 2013, 62, 10, 1497

    CrossRef

  11. 11
    Ravi K. Prakash, Sowjanya Kanna, Kevin D. Mullen, Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis, Clinical Therapeutics, 2013, 35, 9, 1458

    CrossRef

  12. 12
    H.S. Chung, D.H. Jung, C.S. Park, Intraoperative Predictors of Short-Term Mortality in Living Donor Liver Transplantation Due to Acute Liver Failure, Transplantation Proceedings, 2013, 45, 1, 236

    CrossRef

  13. 13
    Luis Calzadilla Bertot, Eduardo Vilar Gomez, Linnet Alonso Almeida, Enrique Arus Soler, Luis Blanco Perez, Model for End-Stage Liver Disease and liver cirrhosis-related complications, Hepatology International, 2013, 7, 2, 347

    CrossRef

  14. 14
    Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, Chuan-Yong Guo, Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis, Gastroenterology Research and Practice, 2013, 2013, 1

    CrossRef

  15. 15
    Geun Hong, Kwang-Woong Lee, Sukwon Suh, Tae Yoo, Hyeyoung Kim, Min-Su Park, Youngrok Choi, Nam-Joon Yi, Kyung-Suk Suh, The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation, Journal of Korean Medical Science, 2013, 28, 8, 1207

    CrossRef

  16. You have free access to this content16
    Piero Amodio, Chantal Bemeur, Roger Butterworth, Juan Cordoba, Akinobu Kato, Sara Montagnese, Misael Uribe, Hendrik Vilstrup, Marsha Y. Morgan, The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus, Hepatology, 2013, 58, 1
  17. 17
    Z. Poh, P. E. J. Chang, A Current Review of the Diagnostic and Treatment Strategies of Hepatic Encephalopathy, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  18. 18
    Jasmohan S. Bajaj, Leroy R. Thacker, Douglas M. Heuman, Richard K. Sterling, R. Todd Stravitz, Arun J. Sanyal, Velimir Luketic, Michael Fuchs, Ho Chong S. Gilles, James B. Wade, Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: A prospective study, Liver Transplantation, 2012, 18, 10
  19. 19
    Guy W. Neff, Michael Jones, Taylor Broda, Mark Jonas, Ravinuthala Ravi, David Novick, Tiffany E. Kaiser, Nyingi Kemmer, Durability of Rifaximin Response in Hepatic Encephalopathy, Journal of Clinical Gastroenterology, 2012, 46, 2, 168

    CrossRef

  20. 20
    Carmina Montoliu, Gabriel Gonzalez-Escamilla, Mercedes Atienza, Amparo Urios, Olga Gonzalez, Abdallah Wassel, Roberto Aliaga, Remedios Giner-Duran, Miguel A. Serra, Jose M. Rodrigo, Vicente Belloch, Vicente Felipo, Jose L. Cantero, Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy, NeuroImage, 2012, 61, 4, 1165

    CrossRef

  21. 21
    Vandana Khungar, Fred Poordad, Hepatic Encephalopathy, Clinics in Liver Disease, 2012, 16, 2, 301

    CrossRef

  22. 22
    Ren Chengshan, Wang Lei, Zhao Xiaoyan, Yang Shiming, Zhang Yanqi, Wang Xiwen, Bo Jianying, Zhang Pengbin, Guo Hong, Ling Xianlong, Li Yihui, Da Siping, Xie Xia, Ren Wei, Li Chunhua, Qian Guisheng, Hepatic encephalopathy complicated with hyponatremia and acid-base disturbance and its prognosis, Journal of Medical Colleges of PLA, 2012, 27, 3, 143

    CrossRef

  23. 23
    Ji-Dong Jia, Lactulose in the treatment of hepatic encephalopathy: New evidence for an old modality, Journal of Gastroenterology and Hepatology, 2012, 27, 8
  24. 24
    Vandana Khungar, Fred Poordad, Management of Overt Hepatic Encephalopathy, Clinics in Liver Disease, 2012, 16, 1, 73

    CrossRef

  25. 25
    Toufic Kachaamy, Jasmohan S. Bajaj, Douglas M. Heuman, Muscle and Mortality in Cirrhosis, Clinical Gastroenterology and Hepatology, 2012, 10, 2, 100

    CrossRef

  26. 26
    Yoko Murai, Satoko Ohfuji, Wakaba Fukushima, Akiko Tamakoshi, Shohei Yamaguchi, Makoto Hashizume, Fuminori Moriyasu, Yoshio Hirota, Prognostic factors in patients with idiopathic portal hypertension: Two Japanese nationwide epidemiological surveys in 1999 and 2005, Hepatology Research, 2012, 42, 12
  27. 27
    Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang, Revision and update on clinical practice guideline for liver cirrhosis, The Korean Journal of Hepatology, 2012, 18, 1, 1

    CrossRef

  28. 28
    Amit Agrawal, Barjesh Chander Sharma, Praveen Sharma, Shiv Kumar Sarin, Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy, The American Journal of Gastroenterology, 2012, 107, 7, 1043

    CrossRef

  29. 29
    Kathrine Holte, Aleksander Krag, Lise Lotte Gluud, Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy, Hepatology Research, 2012, 42, 10
  30. 30
    Hua-Jun Chen, Yu Wang, Xi-Qi Zhu, Ying Cui, Yu-Chen Chen, Gao-Jun Teng, White matter abnormalities correlate with neurocognitive performance in patients with HBV-related cirrhosis, Journal of the Neurological Sciences, 2012, 321, 1-2, 65

    CrossRef

  31. 31
    Saskia Ditisheim, Emiliano Giostra, Pierre R Burkhard, Nicolas Goossens, Gilles Mentha, Antoine Hadengue, Laurent Spahr, A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis, BMC Gastroenterology, 2011, 11, 1, 134

    CrossRef

  32. 32
    Ming–Hua Zheng, Ke–Qing Shi, Yu–Chen Fan, Hai Li, Chao Ye, Qiong–Qiu Chen, Yong–Ping Chen, A Model to Determine 3-Month Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure, Clinical Gastroenterology and Hepatology, 2011, 9, 4, 351

    CrossRef

  33. 33
    Hugo Mendieta Zerón, Mónica Rodríguez Rodríguez, Sergio Montes, Camilo Ríos Castañeda, Blood manganese levels in patients with hepatic encephalopathy, Journal of Trace Elements in Medicine and Biology, 2011, 25, 4, 225

    CrossRef

  34. 34
    Ming Luo, Lei Li, Chen-Zheng Lu, Wu-Kui Cao, Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2011, 23, 12, 1250

    CrossRef

  35. 35
    Hannelore Ringe, Verena Varnholt, Miriam Zimmering, Werner Luck, Alexander Gratopp, Kai König, Susanne Reich, Igor M. Sauer, Gerhard Gaedicke, Uwe Querfeld, Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure*, Pediatric Critical Care Medicine, 2011, 12, 3, 257

    CrossRef

  36. 36
    Hanan Mardini, Fiona E. Smith, Christopher O. Record, Andrew M. Blamire, Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia, Journal of Hepatology, 2011, 54, 6, 1154

    CrossRef

  37. 37
    Claire Francoz, Jacques Belghiti, Denis Castaing, Olivier Chazouillères, Jean-Charles Duclos-Vallée, Christophe Duvoux, Jan Lerut, Yves-Patrice Le Treut, Richard Moreau, Ameet Mandot, Georges Pageaux, Didier Samuel, Dominique Thabut, Dominique Valla, François Durand, Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system, Liver Transplantation, 2011, 17, 10
  38. 38
    Marta Martín–Llahí, Mónica Guevara, Aldo Torre, Claudia Fagundes, Tea Restuccia, Rosa Gilabert, Elsa Solá, Gustavo Pereira, Marcella Marinelli, Marco Pavesi, Javier Fernández, Juan Rodés, Vicente Arroyo, Pere Ginès, Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis, Gastroenterology, 2011, 140, 2, 488

    CrossRef

  39. 39
    Anastasia Rivkin, Suzanna Gim, Rifaximin: New Therapeutic Indication and Future Directions, Clinical Therapeutics, 2011, 33, 7, 812

    CrossRef

  40. 40
    Lewis W. Teperman, Vincent P. Peyregne, Considerations on the Impact of Hepatic Encephalopathy Treatments in the Pretransplant Setting, Transplantation, 2010, 89, 7, 771

    CrossRef

  41. 41
    Charmaine A. Stewart, Felicity T. B. Enders, Niccole Schneider, Donna Felmlee-Devine, Patrick S. Kamath, Glenn E. Smith, Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy, Liver International, 2010, 30, 6
  42. 42
    Ravi Prakash, Kevin D. Mullen, Mechanisms, diagnosis and management of hepatic encephalopathy, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 9, 515

    CrossRef

  43. 43
    Jasmohan S. Bajaj, Christine M. Schubert, Douglas M. Heuman, James B. Wade, Douglas P. Gibson, Allyne Topaz, Kia Saeian, Muhammad Hafeezullah, Debulon E. Bell, Richard K. Sterling, R. Todd Stravitz, Velimir Luketic, Melanie B. White, Arun J. Sanyal, Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy, Gastroenterology, 2010, 138, 7, 2332

    CrossRef

  44. You have free access to this content44
    J. S. BAJAJ, Review article: the modern management of hepatic encephalopathy, Alimentary Pharmacology & Therapeutics, 2010, 31, 5
  45. 45
    Kevin Mullen, Ravi Prakash, Rifaximin for the treatment of hepatic encephalopathy, Expert Review of Gastroenterology & Hepatology, 2010, 4, 6, 665

    CrossRef

  46. 46
    P.S. Mantry, S. Munsaf, Rifaximin for the Treatment of Hepatic Encephalopathy, Transplantation Proceedings, 2010, 42, 10, 4543

    CrossRef

  47. 47
    Nathan M. Bass, Kevin D. Mullen, Arun Sanyal, Fred Poordad, Guy Neff, Carroll B. Leevy, Samuel Sigal, Muhammad Y. Sheikh, Kimberly Beavers, Todd Frederick, Lewis Teperman, Donald Hillebrand, Shirley Huang, Kunal Merchant, Audrey Shaw, Enoch Bortey, William P. Forbes, Rifaximin Treatment in Hepatic Encephalopathy, New England Journal of Medicine, 2010, 362, 12, 1071

    CrossRef

  48. 48
    Jordi Colmenero, Graciela Castro-Narro, Miguel Navasa, Utilidad del MELD (Model for End-stage Liver Disease) para asignar prioridades en el trasplante hepático, Gastroenterología y Hepatología, 2010, 33, 4, 330

    CrossRef

  49. 49
    Juan F. Gallegos-Orozco, Hugo E. Vargas, Liver Transplantation: From Child to MELD, Medical Clinics of North America, 2009, 93, 4, 931

    CrossRef

  50. You have free access to this content50
    Hui-Chun Huang, Fa-Yauh Lee, Teh-Ia Huo, Major adverse events, pretransplant assessment and outcome prediction, Journal of Gastroenterology and Hepatology, 2009, 24, 11
  51. 51
    V. Stadlbauer, G. A. K. Wright, R. Jalan, Role of artificial liver support in hepatic encephalopathy, Metabolic Brain Disease, 2009, 24, 1, 15

    CrossRef

  52. 52
    Jasmohan S. Bajaj, James B. Wade, Arun J. Sanyal, Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy, Hepatology, 2009, 50, 6
  53. 53
    Piero Amodio, The liver, the brain and nitrogen metabolism, Metabolic Brain Disease, 2009, 24, 1, 1

    CrossRef

  54. 54
    Teh-Ia Huo, Han-Chieh Lin, Samantha C. Huo, Pui-Ching Lee, Jaw-Ching Wu, Fa-Yauh Lee, Ming-Chih Hou, Shou-Dong Lee, Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis, Liver Transplantation, 2008, 14, 6
  55. 55
    Santiago J. Munoz, Hepatic Encephalopathy, Medical Clinics of North America, 2008, 92, 4, 795

    CrossRef

  56. 56
    Isabel Campos-Varela, Lluís Castells, Puntuaciones de pronóstico de la cirrosis, Gastroenterología y Hepatología, 2008, 31, 7, 439

    CrossRef

  57. 57
    Teh-Ia Huo, Shou-Dong Lee, Han-Chieh Lin, Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond, Liver International, 2008, 28, 5
  58. 58
    Charmaine A Stewart, Glenn E Smith, Minimal hepatic encephalopathy, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 12, 677

    CrossRef

  59. 59
    Julia Gore Thornton, Kevin D. Mullen, The role of hepatic encephalopathy in the era of MELD, Liver Transplantation, 2007, 13, 10
  60. 60
    Marsha Y. Morgan, Hepatic Encephalopathy in Patients with Cirrhosis,
  61. 61
    Nayantara Coelho-Prabhu, Patrick S. Kamath, Portal Hypertension,